This month’s column is about three molecules, a mom, a tenacious father-in-law and a biotech breakthrough with huge possible implications for people with spinal cord injuries.
How does spinal cord injury research get paid for? It’s an issue I’ve been trying to understand for the better part of two decades.
What if it were possible to replace lost neurons by combining superfast, individual-specific 3D printing with cellular therapy designed to promote axon growth? Turns out that it is possible.
If ever there was an industry that could use some disruption, SCI research is it.
Axons carry your thoughts (brain signals) through the cord to other neurons and eventually on to your muscles. Broken axons are why people stay paralyzed.
This month’s story involves giving the brain a chance to reconnect to the cord below the injury site in a different, and potentially more exciting, way.
“Improved voluntary hand function occurred within a single session in every subject tested." That’s the killer sentence from a new study soon to be published.
I struggle when it comes to the idea of going to Bangkok for a stimulator that’s manufactured by an American company.